Compare Cardinal Health Inc (CAH) vs JetBlue Airways Corporation (JBLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs JetBlue Airways Corporation — how do they compare? Cardinal Health Inc trades at $229 (market cap $54.72B), while JetBlue Airways Corporation trades at $5.34 (market cap $2.08B). The key difference: Cardinal Health Inc is far larger — about 26.3× JetBlue Airways Corporation's market cap, and Cardinal Health Inc pays a 0.88% dividend while JetBlue Airways Corporation pays none. Which is the better fit depends on your goals.
| CAH | JBLU | |
|---|---|---|
Market Cap | $54.72B | $2.08B |
Sector | Health | Industrials |
52-Week High | $239.71 | $6.46 |
52-Week Low | $146.04 | $4.03 |
Enterprise Value | $59.70B | $9.25B |
Dividend Yield | 0.88% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
JetBlue (JBLU) trades at $5.60, down 2.78% on the day, with a neutral technical signal and mixed fundamental picture. The airline reported negative net income margins of -7.78% and has missed earnings expectations in recent quarters, though it beat in Q3 2025. Recent news highlights expansion at Fort Lauderdale airport and sector-wide pressure from fuel costs. Analyst consensus is mixed with 61% hold ratings and a $5.12 price target slightly below current levels.
The outlook remains challenging with persistent losses and high debt levels, though strategic expansions and potential fuel cost relief offer some upside. Key risks include competitive pressures, volatile fuel prices, and execution of turnaround efforts. The stock presents a speculative opportunity for investors betting on operational improvements amid sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →
